RESTORIL

Add Drug

Prices & Coupons

133RD STREET PHARMACY INC

1473 Amsterdam Ave
New York NY 10027
(212)491-4911

$6.40

 Get Your Coupon

AHF PHARMACY

475 Atlantic Ave
Brooklyn NY 11217
(718)637-2970

$6.40

 Get Your Coupon 1 more results found for AIDS HEALTHCARE FOUNDATION

ALICE RX CORP

231 S 3 Rd St
Brooklyn NY 11211
(718)502-6969

$6.40

 Get Your Coupon 5 more results found for PHARMACY FIRST

DANNY'S PHARMACY II

110 W End Ave
New York NY 10023
(212)362-0000

$6.40

 Get Your Coupon

A.M. PHARMACY II, INC

223 Grand Street
New York NY 10013
(212)226-8832

$6.50

 Get Your Coupon 5 more results found for ALIGNRX (783)

ACME PHARMACY #1083

125 18 Th St
Jersey City NJ 07310
(201)418-0585

$6.68

 Get Your Coupon 1 more results found for NEW ALBERTSONS LP

1699 FANCY PHARMACY INC

132 Allen St
New York NY 10002
(212)529-4532

$7.00

 Get Your Coupon 24 more results found for ELEVATE PROVIDER NETWORK 904

ARROW PHARMACY

883 9 Th Ave
New York NY 10019
(212)245-8469

$7.00

 Get Your Coupon 7 more results found for EPIC PHARMACY NETWORK INC

139 CENTER PHARMACY, LLC

139 Centre Street
New York NY 10013
(646)838-6388

$7.40

 Get Your Coupon 67 more results found for LEADER DRUG STORES INC

137 MOTT PHARMACY, INC.

137 Mott St
New York NY 10013
(646)669-8220

$7.50

 Get Your Coupon 10 more results found for HEALTH MART ATLAS 605

79TH STREET PHARMACY

215 W 79 Th St
New York NY 10024
(646)370-5978

$7.50

 Get Your Coupon 13 more results found for HEALTH MART ATLAS 630

CARE PLUS CVS/PHARMACY #02546

1200 Harbor Blvd
Weehawken NJ 07086
(201)330-8147

$8.00

 Get Your Coupon 76 more results found for CVS PHARMACY INC

CVS PHARMACY # 17820

10 Union Sq E
New York NY 10003
(212)895-9917

$8.00

 Get Your Coupon 11 more results found for CVS PHARMACY IN TARGET

CVS PHARMACY #02919

126 Eighth Ave
New York NY 10011
(800)362-7828

$8.00

 Get Your Coupon

COMMUNITY, A WALGREENS PHARMACY #16463

29 W 116 Th St
New York NY 10026
(212)519-8346

$12.00

 Get Your Coupon

APICHA HEALTH CENTER PHARMACY

400 Broadway
New York NY 10013
(844)370-6202

$12.50

 Get Your Coupon 4 more results found for MAXORXPRESS

CHELSEA ROYAL CARE PHARMACY, INC.

154 9 Th Ave
New York NY 10011
(212)255-8000

$12.50

 Get Your Coupon

CHRONOS PHARMACY

30 96 36 Th Street
Astoria NY 11103
(718)932-8700

$12.50

 Get Your Coupon

COLUMBIA DRUGS

55 Columbia St
New York NY 10002
(212)533-8120

$12.50

 Get Your Coupon

CONTIGO PHARMACY

3510 Bergenline Ave
Union City NJ 07087
(201)500-9366

$12.50

 Get Your Coupon 1 more results found for GERIMED LTC NETWORK INC

COSTCO PHARMACY #1062

517 E 117 Th St
New York NY 10035
(212)896-5882

$12.50

 Get Your Coupon 1 more results found for COSTCO PHARMACIES

Pregnancy

Pregnancy Pregnancy Category X (see CONTRAINDICATIONS ).

Drug Interactions

Drug Interactions The concomitant use of benzodiazepines and opioids increases the risk of respiratory depression because of actions at different receptor sites in the CNS that control respiration. Benzodiazepines interact at GABAA sites and opioids interact primarily at mu receptors. When benzodiazepines and opioids are combined, the potential for benzodiazepines to significantly worsen opioid-related respiratory depression exists. Limit dosage and duration of concomitant use of benzodiazepines and opioids, and monitor patients closely for respiratory depression and sedation. The pharmacokinetic profile of temazepam does not appear to be altered by orally administered cimetidine dosed according to labeling.

Indications And Usage

INDICATIONS AND USAGE Restoril™ (temazepam) is indicated for the short-term treatment of insomnia (generally 7 to 10 days). For patients with short-term insomnia, instructions in the prescription should indicate that Restoril™ (temazepam) should be used for short periods of time (7 to 10 days). The clinical trials performed in support of efficacy were 2 weeks in duration with the final formal assessment of sleep latency performed at the end of treatment.

Overdosage

OVERDOSAGE Manifestations of acute overdosage of Restoril can be expected to reflect the CNS effects of the drug and include somnolence, confusion, and coma, with reduced or absent reflexes, respiratory depression, and hypotension. The oral LD50 of Restoril was 1963 mg/kg in mice, 1833 mg/kg in rats, and >2400 mg/kg in rabbits. Treatment If the patient is conscious, vomiting should be induced mechanically or with emetics. Gastric lavage should be employed utilizing concurrently a cuffed endotracheal tube if the patient is unconscious to prevent aspiration and pulmonary complications. Maintenance of adequate pulmonary ventilation is essential. The use of pressor agents intravenously may be necessary to combat hypotension. Fluids should be administered intravenously to encourage diuresis. The value of dialysis has not been determined. If excitation occurs, barbiturates should not be used. It should be borne in mind that multiple agents may have been ingested. Flumazenil (Romazicon®)*, a specific benzodiazepine receptor antagonist, is indicated for the complete or partial reversal of the sedative effects of benzodiazepines and may be used in situations when an overdose with a benzodiazepine is known or suspected. Prior to the administration of flumazenil, necessary measures should be instituted to secure airway, ventilation, and intravenous access. Flumazenil is intended as an adjunct to, not as a substitute for, proper management of benzodiazepine overdose. Patients treated with flumazenil should be monitored for re-sedation, respiratory depression, and other residual benzodiazepine effects for an appropriate period after treatment. The prescriber should be aware of a risk of seizure in association with flumazenil treatment, particularly in long-term benzodiazepine users and in cyclic antidepressant overdose. The complete flumazenil package insert including CONTRAINDICATIONS, WARNINGS, and PRECAUTIONS should be consulted prior to use. Up-to-date information about the treatment of overdose can often be obtained from a certified Regional Poison Control Center. Telephone numbers of certified Regional Poison Control Centers are listed in the Physicians' Desk Reference®**.

Adverse Reactions

ADVERSE REACTIONS During controlled clinical studies in which 1076 patients received Restoril at bedtime, the drug was well tolerated. Side effects were usually mild and transient. Adverse reactions occurring in 1% or more of patients are presented in the following table: Restoril % Incidence (n=1076) Placebo % Incidence (n=783) Drowsiness 9.1 5.6 Headache 8.5 9.1 Fatigue 4.8 4.7 Nervousness 4.6 8.2 Lethargy 4.5 3.4 Dizziness 4.5 3.3 Nausea 3.1 3.8 Hangover 2.5 1.1 Anxiety 2.0 1.5 Depression 1.7 1.8 Dry Mouth 1.7 2.2 Diarrhea 1.7 1.1 Abdominal Discomfort 1.5 1.9 Euphoria 1.5 0.4 Weakness 1.4 0.9 Confusion 1.3 0.5 Blurred Vision 1.3 1.3 Nightmares 1.2 1.7 Vertigo 1.2 0.8 The following adverse events have been reported less frequently (0.5% to 0.9%): Central Nervous System – anorexia, ataxia, equilibrium loss, tremor, increased dreaming Cardiovascular – dyspnea, palpitations Gastrointestinal – vomiting Musculoskeletal – backache Special Senses – hyperhidrosis, burning eyes Amnesia, hallucinations, horizontal nystagmus, and paradoxical reactions including restlessness, overstimulation and agitation were rare (less than 0.5%).

Contraindications

CONTRAINDICATIONS Benzodiazepines may cause fetal harm when administered to a pregnant woman. An increased risk of congenital malformations associated with the use of diazepam and chlordiazepoxide during the first trimester of pregnancy has been suggested in several studies. Transplacental distribution has resulted in neonatal CNS depression following the ingestion of therapeutic doses of a benzodiazepine hypnotic during the last weeks of pregnancy. Reproduction studies in animals with temazepam were performed in rats and rabbits. In a perinatal-postnatal study in rats, oral doses of 60 mg/kg/day resulted in increasing nursling mortality. Teratology studies in rats demonstrated increased fetal resorptions at doses of 30 and 120 mg/kg in one study and increased occurrence of rudimentary ribs, which are considered skeletal variants, in a second study at doses of 240 mg/kg or higher. In rabbits, occasional abnormalities such as exencephaly and fusion or asymmetry of ribs were reported without dose relationship. Although these abnormalities were not found in the concurrent control group, they have been reported to occur randomly in historical controls. At doses of 40 mg/kg or higher, there was an increased incidence of the 13th rib variant when compared to the incidence in concurrent and historical controls. Restoril is contraindicated in women who are or may become pregnant. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. Patients should be instructed to discontinue the drug prior to becoming pregnant. The possibility that a woman of childbearing potential may be pregnant at the time of institution of therapy should be considered.

Nursing Mothers

Nursing Mothers It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Restoril is administered to a nursing woman.